xequelbio_digital.jpg
Xequel Bio Announces Positive Results from Phase 1b Study of iNexin™, a Novel aCT1 Ophthalmic Solution
July 14, 2022 09:00 ET | Xequel Bio, Inc.
Excellent Safety and Tolerability Profile for iNexin™ for the Treatment of Corneal Injury Early Efficacy Signals Provide Rationale to Advance to Phase 2 Proprietary aCT1 Platform to Address Unmet...
22157.jpg
Global Smart Contact Lenses Industry Report 2022-2027: Growth, Trends and Opportunity Forecasts
July 14, 2022 04:13 ET | Research and Markets
Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Smart Contact Lenses Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)" report has been added to ResearchAndMarkets.com's offering....
Optical Coherence Tomography (OCT) for Ophthalmology Global Market Report 2022: OCT Angiography and Combo OCT/Fundus Systems Present Opportunities
July 13, 2022 05:38 ET | Research and Markets
Dublin, July 13, 2022 (GLOBE NEWSWIRE) -- The "Optical Coherence Tomography (OCT) for Ophthalmology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's...
logo color s and clearside.jpg
Clearside Biomedical Suprachoroidal Delivery Technology to be Featured at Upcoming ASRS and OIS Medical Meetings
July 07, 2022 07:05 ET | Clearside Biomedical, Inc.
- Multiple Podium and Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - ALPHARETTA, Ga., July 07, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:...
22157.jpg
Outlook on the Ophthalmoscopes Global Market to 2027 - Rise in Eye Disorder Prevalence & Surgical Procedures is Driving Growth
July 07, 2022 05:03 ET | Research and Markets
Dublin, July 07, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. Ophthalmoscope...
MicrosoftTeams-image (5).png
Value of Wearable Medical Devices Market Estimated at US$ 183.8 Bn by 2031, TMR Report
July 06, 2022 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 06, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: Analysts at TMR estimate the wearable medical devices market to expand at a CAGR of 19.1%...
RG logo 7.png
RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.
July 06, 2022 08:00 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc.,...
DBMR Logo.png
Ophthalmology Drugs and Devices Market to Exhibit 5.80% CAGR; Industry Size, Market Share, Trends, Growth Factors and Regional Outlook to 2029
July 05, 2022 15:18 ET | Data Bridge Market Research
WILMINGTON, DELAWARE, July 05, 2022 (GLOBE NEWSWIRE) -- DBMR have recently added a report titled ‘Ophthalmology Drugs and Devices Market’ Report to our extensive database of reports. Our team of...
CareMetx and USRetina Partner to Better Support Ophthalmology and Retina Patients
June 28, 2022 15:35 ET | CareMetx, LLC
Bethesda, MD, June 28, 2022 (GLOBE NEWSWIRE) -- CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, and USRetina, the largest...
Oyster_Point_RegisteredTM_Logo_RGB.jpg
Oyster Point Pharma Research Selected for Top 5 Poster Session at American Optometric Association's Optometry's Meeting®
June 15, 2022 07:55 ET | Oyster Point Pharma, Inc.
PRINCETON, N.J., June 15, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization...